英語ページ

Publications 2002

  1. Wang L, Habuchi T, Takahashi T, Mitsumori K, Kamoto T, Kakehi Y, Kakinuma H,Sato K, Nakamura A, Ogawa O, Kato T (2002). Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23: 257-264.
  2. Wang L, Habuchi T, Takahashi T, Kamoto T, Zuo T, Mitsumori K, Tsuchiya N,Sato K, Ogawa O, Kato T (2002). No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer. Int J Cancer 97: 787-790.
  3. Tsuchiya N, Slezak JM, Lieber MM, Bergstralh EJ and Jenkins RB. (2002) Clinical significance of alterations of chromosome 8 detected by FISH analysis in pathologic organ-confined prostate cancer. Genes, Chromosomes & Cancer, 34: 363-371.
  4. Tsuchiya N,Takahashi A,Kondo Y,Pawar H, Qian J,Sato K, Lieber MM and Jenkins RB. (2002) Mapping and gene expression profile of the minimally overrepresented 8q23-q24 region in prostate cancer. Am J Pathol, 160, 1799-1806.
  5. Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, and Knowles MA. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines. Genes Chromosomes Cancer. 2002 May;34(1):86-96.
  6. Satoh S, Iinuma K, Mitsumori S, Matsuura N, Shimoda K, Sato K, Habuchi T, Kato T. (2002) The number of peripheral CD4CD25 cells and early postoperative episodes in renal transplantation. Transplant. Proc. 34, 1755-1756.
  7. Satoh S, Suzuki A, Asari Yasushi, Sato M, Kojima N, Sato T, Tsuchiya N, Sato K, Senoo H, Kato T. (2002) Glomerular endothelial exhibits enhanced expression of costimulatory adhesion molecules, CD80 and CD86, by warm ischemia/reperfusion injury in rats. Lab. Invest. 82, 1209-1217.
  8. Satoh S, Sato K, Habuchi T, Matsuo S, Sasaki S, Kato T. (2002) Health-related quality of life of ileocecal rectal bladder compared with ileal conduit diversion: a questionnaire survey. Int. J. Urol. 9, 385-391.
  9. Satoh S, Sugimura J, Omori S, Seino K, Fujizuka I. (2002) Long-term graft survival with or without donor-specific transfusion in cyclosporine era in one haplo-identical living0related renal transplant recipients beyond the first year: a 19-year experience. Tohoku J. Exp. Med. 197: 201-207.
  10. Yoshida H, Okuno H, Kamoto T, Habuchi T, Toda Y, Hasegawa S, Nakamura T, Wada H, Ogawa O, Yamamoto S. Comparison of the effectiveness of ET-Kyoto with Euro-Collins and University of Wisconsin solutions in cold renal storage. Transplantation. 2002 Nov 15;74(9):1231-6.
  11. Abe, A., Sato, K., Habuchi, T., Wang, L., Li Z., Tsuchiya, N., Ohyama, C., Satoh ,S., Ogawa, O., and Kato T. (2002) Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma.Tohoku J. Exp. Med. 198,181-190.
  12. Hoshi,S., Jokura, H., Nakamura, H., Shintaku, I., Ohyama, C., Satoh, M., Saito, S., Fukuzaki, A., Orikasa,S., and Yoshimoto, T. (2002) Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: Results in 42 patients. Int. J. Urol. 9,618-625.
  13. Ohyama, C., Kanto, S., Kato, K., Nakano, O., Kato, T., Arai, Y., Shihao, Chen, Fukuda, N.M., and Fukuda, M. (2002) Natural killer cells attack tumor cells expressing high level of sialyl Lewis X oligosaccharides. Proc.Natl.Acad.Sci. USA., 99,13789-13794.
  14. Ohyama, C., Chiba,Y., Yamazaki, T., Endoh, M., Hoshi, S., and Arai, Y. (2002) Lymphatic mapping and gamma probe guided laparoscopic biopsy of sentinel lymph node in patients with clinical stage I testicular tumor. J Urol. 168,1390-1395, 2002.
  15. Saito, S., Yamashita S., Endoh M., Yamato T., Hoshi S., Ohyama C., Watanabe R., Ito A., Satoh M., Wada T., Paulson JC., Arai Y., and Miyagi T. (2002) Clinical significance of STGal IV inhuman renal cell carcinoma. Oncol. Rep., 9,1251-1255.
  16. Zhang, J., Nakayama, J., Ohyama, C., Suzuki, M., Suzuki, A., Fukuda, M., and Fukuda, M.N. (2002) Sialyl Lewis X-dependent lung colonization of B16 Melanoma cells through a selectin-like endothelial receptor distinct from E- or P-selectin. Cancer Res., 62, 4194-4198.
  17. Nakamura E, Megumi Y, Kobayashi T, Kamoto T, Ishitoya S, Terachi T, Tachibana M, Matsushiro H, Habuchi T, Kakehi Y and Ogawa O. (2002) Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. Clin Cancer Res. 8, 2620-5.
  18. Watanabe, R., Ohyama, C., Aoki, H., Takahashi, T., Satoh, M., Saito, S., Hoshi, S., Ishii, A ., Saito, M., and Arai, Y. (2002) Ganglioside GM3 over-expression induces apoptosis and reduces malignant potential in murine bladder cancer. Cancer Res., 62, 3850-4.
  19. Kamoto T, Satomura S, Yoshiki T, Okada Y, Henmi F, Nishiyama H, Kobayashi T, Terai A, Habuchi T, Ogawa O. (2002) Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors. Jpn J Clin Oncol. ;32(11): 472-476.
  20. Ohyama, C., Kyan, A., Satoh, M., Saito, S., Nishimura, Y., Imai, Y., Oikawa, K., Yokoyama, J., Suzuki, K., Takeichi, M., Hoshi, S., and Orikasa, S. (2002) Bilateral testicular tumors: A report of 9 cases with a long-term follow-up. Int.J.Urol., 9,173-177.
  21. Ogata Y., Ishidoya S., Fukuzaki A., Kaneto H., Takeda A., Ohyama C., Orikasa S., and Arai Y.(2002) Upregulated expression of transforming growth factor-b, type IV collagen, and plasminogen activator inhibitor-1 mRNA are decreased after release of unilateral ureteral obstruction. Tohoku J.Exp.Med. 197,159-168.
  22. Ito A., Satoh M., Ohyama C., Hoshi S., Orikasa S. (2002) Adrenal metastasis from renal cell carcinoma: Significance of adrenalectomy. Int. J. Urol. 9,125-128.
  23. Akama, T. O., Sugihara, K., Nakagawa, H., Sugihara, K., Narisawa, S., Ohyama, C., Nishimura, S., OユBrien, DA., Moremen, K.W., Millan, J.L., and Fukuda M.N. (2002) Germ cell survival through carbohydrate-mediated Sertoli cells. Science, 295, 124-127.
  24. Yamashita S., Ohyama C., Takeuchi A., Nakagawa H., Watanabe M., and Hoshi S. (2002) Primary choriocarcinoma in the posterior mediastinum. J. Urol., 167,1789.
  25. Kanto S., Ohyama C., Okada Y., Mitsukawa S., Takemoto J., Hoshi S and Orikasa S. (2002) The clinical features of prostate cancer patients younger than fifty. Int. J. Urol ., 9, 91-94.
  26. Numahata K., Satoh M., Handa K., Saito S., Ohyama C., Ito A., Takahashi T., Hoshi S., Orikasa S., and Hakomori S. (2002) Sialyl Lewis X expression defines invasive and metastatic properties of bladder carcinoma. Cancer, 94, 363-383.
  27. Matsuura S, Kakizaki H, Mitsui T, Shiga T, Tamaki N, Koyanagi T. (2002) Human brain region response to distention or cold stimulation of the bladder: a positron emission tomography study. J Urol., 168(5), 2035-2039.
  28. Machino R, Kakizaki H, Ameda K, Shibata T, Tanaka H, Matsuura S, Koyanagi T. (2002) Detrusor instability with equivocal obstruction: A predictor of unfavorable symptomatic outcomes after transurethral prostatectomy. Neurourol Urodyn., 21(5), 444-449.
  29. Mitsui T, Kakizaki H, Matsuura S, Tanaka H, Ameda K, Yoshioka M, Koyanagi T. (2002) NK(1) receptor and its interaction with NMDA receptor in spinal c-fos expression after lower urinary tract irritation. Am J Physiol., 283(3), R576-582.
  30. 羽渕友則,飯沼昌宏,佐藤一成,佐藤 滋,松浦 忍,下田直威,土谷順彦,光森健二,加藤哲郎(2002) 秋田大学における腹腔鏡下前立腺全摘除術15例の早期成績. 泌尿紀要48, 139-144.
  31. 鈴木 明,佐藤 滋,土谷順彦,加藤哲郎,佐藤 充,妹尾春樹(2002) ラット虚血腎における副刺激シグナル系細胞接着因子CD80の発現亢進. 日泌尿会誌93, 33-38.
  32. 畠山真吾,羽渕友則,市村 靖,秋濱 晋,寺井康詞郎,柿沼秀秋,赤尾利弥,佐藤 滋,加藤哲郎(2002) 妊娠を契機として急速に増大した下静脈腫瘍血栓を伴った腎血管筋脂肪腫の1例. 日泌尿会誌93, 48-51.
  33. 上田 勉,佐藤 滋,柿沼秀秋,立木 裕,三品睦輝,土谷順彦,赤尾利弥,下田直威,佐藤一成,羽渕友則,加藤哲郎(2002)  生体腎移植におけるドナー腎摘出術の安全性. 秋田医学29, 9-12.
  34. 井上高光,佐藤 滋,沼倉一幸,松浦 忍,飯沼昌宏,光森健二,土谷順彦,下田直威,佐藤一成,羽渕友則,加藤哲郎(2002) 高齢者レシピエントに著しい全身動脈硬化を認めた夫婦間生体腎移植の1例. 移植37,88-91.
  35. 井上高光,羽渕友則,下田直威,佐藤 滋,佐藤一成,加藤哲郎,南谷佳弘,小川純一,松尾重樹,佐々木秀平(2002)救済外科療法で長期寛解を得た化学療法抵抗性精巣腫瘍の1例.日泌尿会誌93, 715-718.
  36. 飯沼昌宏,佐藤 滋,土谷順彦,下田直威,佐藤一成,羽渕友則,加藤哲郎(2002) 後腹膜鏡下ハンドアシストドナー腎摘出術. 日泌尿会誌93, 721-726.
  37. 望月静枝,長沼 廣,森谷卓也,大山 力,桜田ひとみ,天野美奈子,笹野公伸,斉藤喬雄(2002) オスミウム酸固定のパラフィン包埋標本における脂質観察. Therapeutic Res. 23,51-53.
  38. 新宅一郎,沼畑健司,鈴木謙一,大山 力,佐藤 信,斎藤誠一,星 宣次,折笠精一(2002) Etoposideとcisplatinをfirstlineとした進行性精巣腫瘍の治療実績.日泌尿会誌93, 519-524.
  39. 星 宣次,大山 力,並木俊一 (2002)  ホルモン不応性前立腺癌に対する低用量シスプラチンとUFT併用療法. 癌と化学療法 29, 1173-1178.
  40. Ohyama, C., Inaba, Y., Takahashi, T., and Arai, Y. (2002) Gene transfer of a-1,3-fucosyltransferase increasesgrowth and metastatic potential of human prostate cancer cell (PC-3). Prostate Cancer and Prostatic Disease, 5, 26.

メニューを開く